Literature DB >> 12431194

Interleukin-6, interleukin-8, interleukin-11, and interferon-gamma levels in nasopharyngeal aspirates from wheezing children with respiratory syncytial virus or influenza A virus infection.

Jae-Won Oh1, Ha-Baik Lee, Il-Kyu Park, Jung-Oak Kang.   

Abstract

The differences between respiratory syncytial virus (RSV) and influenza A virus (IFAV) in the pathogenesis of wheezing in young children have not been clearly defined. The aim of this study was to assess the contributions of RSV vs IFAV in the pathogenesis of upper airway inflammation in wheezy young children. We compared interleukin (IL)-6, IL-8, IL-11, and interferon-gamma (IFN-gamma) levels in nasopharyngeal aspirates (NPA) from non-asthmatic children with respiratory virus infections (RSV in 17 children and IFAV in 13 children), asthmatic children with viral infections (RSV in nine children, IFAV in 10 children), and 22 unaffected healthy children (controls). Levels of IL-11 in NPA from asthmatic children were significantly higher than those from non-asthmatic children with RSV infection, and RSV infection enhanced the IL-11 production in NPA significantly compared to IFAV infection. Nasopharyngeal epithelium from children with RSV infection secreted more IL-6 than that of children with IFAV infection. There was little difference in the IL-8 and IFN-gamma levels between asthmatic and non-asthmatic children with RSV or IFAV infection. In conclusion, asthma enhanced IL-11 production in RSV infection rather than IFAV infection in early childhood. There was a trend towards greater IL-6 production in RSV infection compared with IFAV infection.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12431194     DOI: 10.1034/j.1399-3038.2002.02018.x

Source DB:  PubMed          Journal:  Pediatr Allergy Immunol        ISSN: 0905-6157            Impact factor:   6.377


  16 in total

Review 1.  Toward primary prevention of asthma. Reviewing the evidence for early-life respiratory viral infections as modifiable risk factors to prevent childhood asthma.

Authors:  Amy S Feldman; Yuan He; Martin L Moore; Marc B Hershenson; Tina V Hartert
Journal:  Am J Respir Crit Care Med       Date:  2015-01-01       Impact factor: 21.405

Review 2.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

Review 3.  Understanding the mechanisms of viral induced asthma: new therapeutic directions.

Authors:  Nicole G Hansbro; Jay C Horvat; Peter A Wark; Philip M Hansbro
Journal:  Pharmacol Ther       Date:  2008-01-29       Impact factor: 12.310

4.  Pneumoviruses infect eosinophils and elicit MyD88-dependent release of chemoattractant cytokines and interleukin-6.

Authors:  Kimberly D Dyer; Caroline M Percopo; Elizabeth R Fischer; Stanislaw J Gabryszewski; Helene F Rosenberg
Journal:  Blood       Date:  2009-08-03       Impact factor: 22.113

5.  Respiratory syncytial virus synergizes with Th2 cytokines to induce optimal levels of TARC/CCL17.

Authors:  Martha M Monick; Linda S Powers; Ihab Hassan; Dayna Groskreutz; Timur O Yarovinsky; Christopher W Barrett; Elaine M Castilow; Delia Tifrea; Steven M Varga; Gary W Hunninghake
Journal:  J Immunol       Date:  2007-08-01       Impact factor: 5.422

6.  IL-17F-induced IL-11 release in bronchial epithelial cells via MSK1-CREB pathway.

Authors:  Mio Kawaguchi; Junichi Fujita; Fumio Kokubu; Shau-Ku Huang; Tetsuya Homma; Satoshi Matsukura; Mitsuru Adachi; Nobuyuki Hizawa
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2009-02-27       Impact factor: 5.464

7.  Increased Survivorship and Altered Cytokine Profile from Treatment of Influenza A H1N1-Infected Mice with Ekybion: A Drug Complex of Natural Extracts and Inorganic Compounds.

Authors:  Christopher Lupfer; Didier Besnouin; Samuel E Tepper; Maciej Maselko; Kristin M Patton; Manoj Pastey
Journal:  Evid Based Complement Alternat Med       Date:  2010-10-19       Impact factor: 2.629

8.  Eosinophil cationic protein and chemokines in nasopharyngeal secretions of infants with respiratory syncytial virus (RSV) bronchiolitis and non-RSV bronchiolitis.

Authors:  Hyun Hee Kim; Mi Hee Lee; Joon Sung Lee
Journal:  J Korean Med Sci       Date:  2007-02       Impact factor: 2.153

9.  Gene silencing in the therapy of influenza and other respiratory diseases: Targeting to RNase P by use of External Guide Sequences (EGS).

Authors:  David H Dreyfus; S Mark Tompkins; Ramsay Fuleihan; Lucy Y Ghoda
Journal:  Biologics       Date:  2007-12

10.  Integrated omics endotyping of infants with respiratory syncytial virus bronchiolitis and risk of childhood asthma.

Authors:  Yoshihiko Raita; Marcos Pérez-Losada; Robert J Freishtat; Brennan Harmon; Jonathan M Mansbach; Pedro A Piedra; Zhaozhong Zhu; Carlos A Camargo; Kohei Hasegawa
Journal:  Nat Commun       Date:  2021-06-14       Impact factor: 17.694

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.